TheProfitWatch

MIST - Milestone Pharmaceuticals Inc. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.12 -0.06 (-2.83%) --- --- --- -0.07 (-3.3%) 0.01 (0.49%) 0.01 (0.49%) 0.01 (0.49%)

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.2
Diluted EPS:
-0.2
Basic P/E:
-10.3
Diluted P/E:
-10.3
RSI(14) 1m:
100.0
VWAP:
2.06
RVol:
0.7721

Events

Period Kind Movement Occurred At
1m Price increase 1m 2.08 +0.04 (+1.96%) Oct 15 09:30

Related News